Gerber Kawasaki Wealth & Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Sell |
13,394
-51,699
| -79% | -$3.57M | 0.04% | 150 |
|
|
2025
Q1 | $4.52M | Sell |
65,093
-18,218
| -22% | -$1.27M | 0.2% | 73 |
|
|
2024
Q4 | $7.17M | Sell |
83,311
-20,773
| -20% | -$1.79M | 0.31% | 61 |
|
|
2024
Q3 | $12.4M | Buy |
104,084
+7,127
| +7% | +$849K | 0.57% | 42 |
|
|
2024
Q2 | $13.8M | Buy |
96,957
+4,680
| +5% | +$668K | 0.69% | 35 |
|
|
2024
Q1 | $11.8M | Buy |
92,277
+25,828
| +39% | +$3.32M | 0.64% | 43 |
|
|
2023
Q4 | $6.87M | Buy |
66,449
+10,182
| +18% | +$1.05M | 0.41% | 51 |
|
|
2023
Q3 | $5.12M | Buy |
56,267
+12,047
| +27% | +$1.1M | 0.35% | 59 |
|
|
2023
Q2 | $3.57M | Buy |
44,220
+8,516
| +24% | +$687K | 0.24% | 73 |
|
|
2023
Q1 | $2.84M | Buy |
35,704
+11,912
| +50% | +$948K | 0.22% | 76 |
|
|
2022
Q4 | $1.61M | Buy |
+23,792
| New | +$1.61M | 0.14% | 94 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | -$4K | – | 809 |
|
|
2021
Q3 | $4K | Buy |
+8
| New | +$4K | ﹤0.01% | 788 |
|